Karo Pharma AB Stock
Karo Pharma AB Stock
Karo Pharma AB is currently one of the favorites of our community with 7 Buy predictions and no Sell predictions.
Based on the current price of 5.44 € the target price of 50 € shows a potential of 819.12% for Karo Pharma AB which would more than double the current price.
Pros and Cons of Karo Pharma AB in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karo Pharma AB vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Karo Pharma AB | - | - | - | - | - | - | - |
| Medivir AB | - | 3.030% | -10.053% | -83.810% | -84.332% | -96.092% | -95.750% |
| Active Biotech AB | - | 35.294% | -33.333% | 2200.000% | -68.276% | -94.588% | -96.647% |
| Actinium Pharmaceuticals Inc. | -1.720% | 10.561% | 21.597% | 15.717% | 16.421% | -87.152% | -86.256% |
Comments
Karooooo (NASDAQ:KARO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo (NASDAQ:KARO) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "strong-buy" rating.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James Financial, Inc.. They now have a $60.00 price target on the stock, up previously from $58.00.
Show more
Ratings data for KARO provided by MarketBeat